11.21 USD
▲+0.65+5.06%
盘后 10.54 -1.19%
2026-08-03
市值
$178.70M
市盈率
—
EPS
-14.10
股息率
—
52 周区间
9.40 – 69.97
成交量
359.38K
Beta
1.69
目标价
42.20
52W 低 9.4052W 高 69.97
价格走势
公司简介
Tonix Pharmaceuticals Holding Corp., a fully integrated biopharmaceutical company, develops and commercializes therapies for central nervous system (CNS) disorders, immunology and immuno-oncology, infectious diseases, and rare diseases in the United States. The company offers TONMYA, a cyclobenzaprine HCl sublingual tablet for the treatment of fibromyalgia. It also markets Zembrace SymTouch and Tosymra for the treatment of acute migraine with or without aura in adults. In addition, the company develops TNX-102 SL, a cyclobenzaprine HCl sublingu...